Cannara Biotech Inc. (LOVFF)
Market Closed
15 Dec, 20:00
OTCQB OTCQB Primary $
1. 30
-0
-0.23%
$
57.88M Market Cap
10.25 P/E Ratio
0% Div Yield
9,420 Volume
0 Eps
$ 1.3
Previous Close Day Range
1.28 1.31
Year Range
0.47 1.42
Want to track LOVFF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 41 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| LOVFF Cannara Biotech Inc. 26 Jan 2026 (In 1 month) | | - | - |
| LOVFF Cannara Biotech Inc. 24 Nov 2025 | | - | 0.03 |
| LOVFF Cannara Biotech Inc. 21 Jul 2025 | | - | - |
| LOVFF Cannara Biotech Inc. 28 Apr 2025 | | - | - |
| LOVFF Cannara Biotech Inc. 5 Dec 2024 | | - | - |
| LOVFF Cannara Biotech Inc. 25 Jul 2024 | | - | 0.02 |
| LOVFF Cannara Biotech Inc. 2 May 2024 | | - | - |
| LOVFF Cannara Biotech Inc. 23 Nov 2023 | | - | - |
LOVFF Earnings Reports FAQ
What is the earnings per share (EPS) for LOVFF?
The current EPS is 0.
What is the company's earnings growth rate?
Over the past 2 years, the earnings growth rate has been approximately 62.96%, reflecting the LOVFF's performance and OTCQB market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2026-01-26, based on the LOVFF's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 0.0264 per share, reported on 2025-11-24. For dividend history, visit the LOVFF Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 49.28, calculated based on the most recent stock price of $1.30.
2025 © Marketlog. All Rights Reserved.
